Andrea Gaedigk
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
2023/04/10 by Chad A. Bousman, Chad Bousman, James M. Stevenson +18 · 28 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Biology #CYP2B6 #CYP2C19 #CYP2D6 #CYP3A4 #Cytochrome P450 #Diet and metabolism studies #Genetics #Genotype #Guideline #Internal medicine #Medicine #Pharmacogenetics #Pharmacogenetics and Drug Metabolism #Serotonin #Serotonin reuptake inhibitor #Treatment of Major Depression
- Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
2016/12/20 by JK Hicks, Katrin Sangkuhl, K Sangkuhl +19 · 26 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Biology #CYP2C19 #CYP2D6 #Cancer Treatment and Pharmacology #Dosing #Genetics #Genotype #Guideline #Internal medicine #Medicine #Pharmacogenetics #Pharmacogenetics and Drug Metabolism #Pharmacology #Treatment of Major Depression #Tricyclic
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update
2022/01/16 by Craig R. Lee, Jasmine A. Luzum, Katrin Sangkuhl +14 · 26 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Active metabolite #Adverse effect #Antiplatelet Therapy and Cardiovascular Diseases #CYP2C19 #Clopidogrel #Genotype #Guideline #Pharmacogenetics #Pharmacogenetics and Drug Metabolism #Platelet Disorders and Treatments #Prodrug
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
2021/01/02 by Kristine R. Crews, Andrew A. Monte, Rachel Huddart +18 · 3 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Diet and metabolism studies #Pharmaceutical studies and practices #Pharmacogenetics and Drug Metabolism
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
2011/12/28 by Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger +5 · 4 citations
Pharmacology, Toxicology and Pharmaceutics · Medicine · #Pharmacogenetics and Drug Metabolism #Cancer Treatment and Pharmacology #Pain Management and Opioid Use
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing
2020/08/08 by John J. Lima, Cameron D. Thomas, Julia Barbarino +19 · 26 citations
Chemistry · Medicine · #Adverse effect #CYP2C19 #Chemistry #Cytochrome P450 #Dosing #Gastroenterology #Gastroesophageal reflux and treatments #Genotype #Guideline #Helicobacter pylori-related gastroenterology studies #Internal medicine #Medicine #Metabolism #Pathology #Pharmacogenetics #Pharmacokinetics #Pharmacology #Potassium and Related Disorders #Proton-pump inhibitor
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update
2020/08/12 by Jason H. Karnes, Allan E. Rettie, Andrew A. Somogyi +13 · 26 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Biology #CYP2C9 #Dermatology #Dosing #Drug #Drug-Induced Adverse Reactions #Epilepsy #Genetics #Genotype #Guideline #Internal medicine #Medicine #Pathology #Pharmaceutical studies and practices #Pharmacogenetics #Pharmacokinetics #Pharmacology #Pharmacovigilance and Adverse Drug Reactions #Phenytoin #Psychiatry #Therapeutic drug monitoring #Therapeutic index #Toxic epidermal necrolysis
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
2014/01/23 by Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger +10 · 2 citations
Pharmacology, Toxicology and Pharmaceutics · Medicine · #Pharmacogenetics and Drug Metabolism #Cancer Treatment and Pharmacology #Pain Management and Opioid Use